cortivazol has been researched along with Adenocarcinoma, Basal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evers, BM; Johnson, B; Lawrence, JL; Srinivasan, G; Thompson, EB; Thompson, JC; Townsend, CM | 1 |
1 other study(ies) available for cortivazol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo.
Topics: Adenocarcinoma; Animals; Cricetinae; Gene Expression; Glucocorticoids; Male; Mesocricetus; Pancreatic Neoplasms; Pregnatrienes; Receptors, Glucocorticoid; RNA, Messenger; RNA, Neoplasm | 1993 |